
Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine strategy by targeting dysregulated transcription. Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine strategy by targeting dysregulated transcription.
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.07521 | -8.08709677419 | 0.93 | 0.9747 | 0.8544 | 203860 | 0.89128352 | CS |
4 | -0.13691 | -13.8055863668 | 0.9917 | 1.025 | 0.8544 | 155917 | 0.93060027 | CS |
12 | -0.04521 | -5.02333333333 | 0.9 | 1.07 | 0.8544 | 190034 | 0.97427519 | CS |
26 | -0.14421 | -14.4354354354 | 0.999 | 1.09 | 0.8 | 208968 | 0.9519315 | CS |
52 | -0.38521 | -31.0653225806 | 1.24 | 1.6 | 0.69 | 266890 | 1.01131248 | CS |
156 | -6.59521 | -88.5263087248 | 7.45 | 8.08 | 0.69 | 287307 | 2.03163738 | CS |
260 | -27.43521 | -96.9784729586 | 28.29 | 39.605 | 0.69 | 277016 | 7.93467404 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.